Jun 16, 2025
1:100
For every 100 shares held, investors received 1. The price per share adjusted from $0.16 to $0.00.
The split itself did not change the total investment value.
Crescent Biopharma, Inc. (CBIO) trades on the NASDAQ Capital Market in the Biotechnology industry.
Crescent Biopharma, Inc. company overviewThe latest split shown was on June 16, 2025. It was a 1-for-100 reverse split, so shareholders received 1 share for every 100 they held.
This history records one reverse split, on June 16, 2025.